当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析

福元医药

(601089)

  

流通市值:80.06亿  总市值:80.06亿
流通股本:4.80亿   总股本:4.80亿

福元医药(601089)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.31亿元,每股收益0.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益368644.53万元,未分配利润150594.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产486911.98万元,负债118267.45万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入830,471,781.493,445,642,486.392,547,022,297.141,655,495,417.22
营业总成本698,838,652.842,942,075,836.892,143,616,163.41,362,185,010.9
营业利润144,423,800.03542,528,607.88435,280,857.09319,042,294.69
利润总额144,323,051.06540,115,197.92433,303,595.87318,619,561.42
净利润130,805,404.74492,077,598.39404,081,251.12292,438,727.97
其他综合收益----
综合收益总额130,805,404.74492,077,598.39404,081,251.12292,438,727.97
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,056,249,962.973,201,162,514.773,118,552,756.373,090,659,828.55
非流动资产合计1,812,869,880.381,615,469,870.291,418,101,246.711,346,177,998.83
资产总计4,869,119,843.354,816,632,385.064,536,654,003.084,436,837,827.38
流动负债合计1,116,824,664.661,189,939,548.361,018,132,717.88987,179,334.85
非流动负债合计65,849,884.5470,611,449.250,416,383.5564,540,446.91
负债合计1,182,674,549.21,260,550,997.561,068,549,101.431,051,719,781.76
归属于母公司股东权益合计3,674,747,575.233,544,556,038.13,456,850,886.683,375,177,940.94
股东权益合计3,686,445,294.153,556,081,387.53,468,104,901.653,385,118,045.62
负债和股东权益合计4,869,119,843.354,816,632,385.064,536,654,003.084,436,837,827.38
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计825,510,187.863,470,729,490.422,587,517,831.851,723,816,059.83
经营活动现金流出小计699,511,648.392,779,977,895.52,097,513,437.781,377,582,240.81
经营活动产生的现金流量净额125,998,539.47690,751,594.92490,004,394.07346,233,819.02
投资活动现金流入小计2,424,339,329.072,427,233,421.841,161,023,838.779,807,742
投资活动现金流出小计2,222,210,936.264,441,823,822.162,729,547,410.291,242,818,231.65
投资活动产生的现金流量净额202,128,392.81-2,014,590,400.32-1,568,523,571.52-1,233,010,489.65
筹资活动现金流入小计-49,900,00049,900,00049,900,000
筹资活动现金流出小计37,253,321.91516,801,755.03502,095,113452,930,887.65
筹资活动产生的现金流量净额-37,253,321.91-466,901,755.03-452,195,113-403,030,887.65
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额290,873,610.37-1,790,740,560.43-1,530,714,290.45-1,289,807,558.28
期末现金及现金等价物余额1,004,633,414.02713,759,803.65973,786,073.631,214,692,805.8
最新报告期:2025-04-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋周豫1.131.321.522025-04-30
TOP↑